About this trial
The leading hypothesis behind this study is that a 3-month frequency of supportive peri-implant care (SPIC) recalls after surgical therapy of implants affected by severe peri-implantitis yields better results when compared to a 6-month frequency. Thus, the primary aim of this randomized clinical trial is to compare 2 different frequencies of SPIC recalls (3 and 6 months) after surgical treatment of severe peri-implantitis in terms of treatment success (absence of implant loss, probing pocket depth (PPD) ≤ 5 mm at all aspects, bleeding on deep probing ≤1 site/implant, no suppuration at all aspects, bone loss \<0.5 mm) at early follow-up (1-year) and implant survival at the 5-year examination. Secondarily, this randomized clinical trial aims to assess the effects of the 2 different frequencies over clinical attachment levels around remaining teeth.
Eligibility criteria
Qualifiers
None
Disqualifiers
systemic diseases (e.g. uncontrolled diabetes mellitus) or chronic use of medications (e.g. corticosteroids, bisphosphonates) likely to influence the outcome of therapy or which contraindicates the study procedures;
smoking >10 cigarettes;
pregnant or nursing women.
history of peri-implantitis treatment on the eligible implants in the previous 6 months;
Trial design
Treatments tested in this trial
- 3-month supportive peri-implant care (SPIC)
- 6-month supportive peri-implant care (SPIC)
Treatment groups
Locations
Sponsors and collaborators
University of Turin, Italy
Lead sponsor
Ege University
Collaborator